ロード中...
Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis
BACKGROUND: The clinical implication of plasma ESR1 mutations in the estrogen receptor (ER)-positive metastatic breast cancer (MBC) patients who had progressed after prior aromatase inhibitor (AI)-based therapy remains controversial. We conducted the first meta-analysis to investigate the prognostic...
保存先:
| 出版年: | Cancer Manag Res |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097501/ https://ncbi.nlm.nih.gov/pubmed/30147360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S173193 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|